Literature DB >> 19357934

Increase in cerebellar neurotrophin-3 and oxidative stress markers in autism.

Elizabeth M Sajdel-Sulkowska1, Ming Xu, Noriyuki Koibuchi.   

Abstract

Autism is a neurodevelopmental disorder characterized by social and language deficits, ritualistic-repetitive behaviors and disturbance in motor functions. Data of imaging, head circumference studies, and Purkinje cell analysis suggest impaired brain growth and development. Both genetic predisposition and environmental triggers have been implicated in the etiology of autism, but the underlying cause remains unknown. Recently, we have reported an increase in 3-nitrotyrosine (3-NT), a marker of oxidative stress damage to proteins in autistic cerebella. In the present study, we further explored oxidative damage in the autistic cerebellum by measuring 8-hydroxydeoxyguanosine (8-OH-dG), a marker of DNA modification, in a subset of cases analyzed for 3-NT. We also explored the hypothesis that oxidative damage in autism is associated with altered expression of brain neurotrophins critical for normal brain growth and differentiation. The content of 8-OH-dG in cerebellar DNA isolated by the proteinase K method was measured using an enzyme-linked immunosorbent assay (ELISA); neurotrophin-3 (NT-3) levels in cerebellar homogenates were measured using NT-3 ELISA. Cerebellar 8-OH-dG showed trend towards higher levels with the increase of 63.4% observed in autism. Analysis of cerebellar NT-3 showed a significant (p = 0.034) increase (40.3%) in autism. Furthermore, there was a significant positive correlation between cerebellar NT-3 and 3-NT (r = 0.83; p = 0.0408). These data provide the first quantitative measure of brain NT-3 and show its increase in the autistic brain. Altered levels of brain NT-3 are likely to contribute to autistic pathology not only by affecting brain axonal targeting and synapse formation but also by further exacerbating oxidative stress and possibly contributing to Purkinje cell abnormalities.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19357934     DOI: 10.1007/s12311-009-0105-9

Source DB:  PubMed          Journal:  Cerebellum        ISSN: 1473-4222            Impact factor:   3.847


  50 in total

1.  Differential patterns of nerve growth factor, brain-derived neurotrophic factor and neurotrophin-3 mRNA and protein levels in developing regions of rat brain.

Authors:  K P Das; S L Chao; L D White; W T Haines; G J Harry; H A Tilson; S Barone
Journal:  Neuroscience       Date:  2001       Impact factor: 3.590

2.  Neurotrophin-3, TNF-alpha and IL-6 relations in serum and cerebrospinal fluid of ischemic stroke patients.

Authors:  Daniela Pasarica; Mihaela Gheorghiu; Florica Topârceanu; Coralia Bleotu; Loretta Ichim; T Trandafir
Journal:  Roum Arch Microbiol Immunol       Date:  2005 Jan-Dec

3.  The evaluation of oxidative DNA damage in children with brain damage using 8-hydroxydeoxyguanosine levels.

Authors:  Miho Fukuda; Hiroshi Yamauchi; Hitoshi Yamamoto; Masahito Aminaka; Hiroshi Murakami; Noriko Kamiyama; Yusaku Miyamoto; Yasushi Koitabashi
Journal:  Brain Dev       Date:  2007-09-04       Impact factor: 1.961

4.  Proximity to point sources of environmental mercury release as a predictor of autism prevalence.

Authors:  Raymond F Palmer; Stephen Blanchard; Robert Wood
Journal:  Health Place       Date:  2008-02-12       Impact factor: 4.078

5.  Protein tyrosine nitration is triggered by nerve growth factor during neuronal differentiation of PC12 cells.

Authors:  Graziella Cappelletti; Maria G Maggioni; Gabriella Tedeschi; Rosalba Maci
Journal:  Exp Cell Res       Date:  2003-08-01       Impact factor: 3.905

6.  An exploration of possible pre- and postnatal correlates of autism: a pilot survey.

Authors:  Gary E Brown; Sherry D Jones; Angie S MacKewn; Esther J Plank
Journal:  Psychol Rep       Date:  2008-02

7.  Evidence for oxidative DNA damage in the hippocampus of elderly patients with chronic schizophrenia.

Authors:  Naoya Nishioka; Steven E Arnold
Journal:  Am J Geriatr Psychiatry       Date:  2004 Mar-Apr       Impact factor: 4.105

8.  Chronic exposure to ethanol alters neurotrophin content in the basal forebrain-cortex system in the mature rat: effects on autocrine-paracrine mechanisms.

Authors:  Michael W Miller; Sandra M Mooney
Journal:  J Neurobiol       Date:  2004-09-15

9.  Increased urinary level of oxidized nucleosides in patients with mild-to-moderate Alzheimer's disease.

Authors:  Sang Hee Lee; Inseong Kim; Bong Chul Chung
Journal:  Clin Biochem       Date:  2007-01-05       Impact factor: 3.281

10.  Analysis of case-parent trios at a locus with a deletion allele: association of GSTM1 with autism.

Authors:  Steven Buyske; Tanishia A Williams; Audrey E Mars; Edward S Stenroos; Sue X Ming; Rong Wang; Madhura Sreenath; Marivic F Factura; Chitra Reddy; George H Lambert; William G Johnson
Journal:  BMC Genet       Date:  2006-02-10       Impact factor: 2.797

View more
  47 in total

1.  Metabolic imbalance associated with methylation dysregulation and oxidative damage in children with autism.

Authors:  Stepan Melnyk; George J Fuchs; Eldon Schulz; Maya Lopez; Stephen G Kahler; Jill J Fussell; Jayne Bellando; Oleksandra Pavliv; Shannon Rose; Lisa Seidel; David W Gaylor; S Jill James
Journal:  J Autism Dev Disord       Date:  2012-03

2.  Postnatal exposure to trichloroethylene alters glutathione redox homeostasis, methylation potential, and neurotrophin expression in the mouse hippocampus.

Authors:  Sarah J Blossom; Stepan Melnyk; Craig A Cooney; Kathleen M Gilbert; S Jill James
Journal:  Neurotoxicology       Date:  2012-03-07       Impact factor: 4.294

Review 3.  Consensus paper: pathological role of the cerebellum in autism.

Authors:  S Hossein Fatemi; Kimberly A Aldinger; Paul Ashwood; Margaret L Bauman; Charles D Blaha; Gene J Blatt; Abha Chauhan; Ved Chauhan; Stephen R Dager; Price E Dickson; Annette M Estes; Dan Goldowitz; Detlef H Heck; Thomas L Kemper; Bryan H King; Loren A Martin; Kathleen J Millen; Guy Mittleman; Matthew W Mosconi; Antonio M Persico; John A Sweeney; Sara J Webb; John P Welsh
Journal:  Cerebellum       Date:  2012-09       Impact factor: 3.847

4.  Altered balance of proteolytic isoforms of pro-brain-derived neurotrophic factor in autism.

Authors:  Kristine L P Garcia; Guanhua Yu; Chiara Nicolini; Bernadeta Michalski; Diego J Garzon; Victor S Chiu; Enrico Tongiorgi; Peter Szatmari; Margaret Fahnestock
Journal:  J Neuropathol Exp Neurol       Date:  2012-04       Impact factor: 3.685

5.  In the search for reliable biomarkers for the early diagnosis of autism spectrum disorder: the role of vitamin D.

Authors:  Afaf El-Ansary; John J Cannell; Geir Bjørklund; Ramesa Shafi Bhat; Abeer M Al Dbass; Hanan A Alfawaz; Salvatore Chirumbolo; Laila Al-Ayadhi
Journal:  Metab Brain Dis       Date:  2018-03-01       Impact factor: 3.584

6.  Is the PentaBDE replacement, tris (1,3-dichloro-2-propyl) phosphate (TDCPP), a developmental neurotoxicant? Studies in PC12 cells.

Authors:  Laura V Dishaw; Christina M Powers; Ian T Ryde; Simon C Roberts; Frederic J Seidler; Theodore A Slotkin; Heather M Stapleton
Journal:  Toxicol Appl Pharmacol       Date:  2011-01-19       Impact factor: 4.219

7.  Brain region-specific deficit in mitochondrial electron transport chain complexes in children with autism.

Authors:  Abha Chauhan; Feng Gu; Musthafa M Essa; Jerzy Wegiel; Kulbir Kaur; William Ted Brown; Ved Chauhan
Journal:  J Neurochem       Date:  2011-02-24       Impact factor: 5.372

8.  Aberrant cerebellar neurotrophin-3 expression induced by lipopolysaccharide exposure during brain development.

Authors:  Ming Xu; Elizabeth M Sajdel-Sulkowska; Toshiharu Iwasaki; Noriyuki Koibuchi
Journal:  Cerebellum       Date:  2013-06       Impact factor: 3.847

9.  Defining the role of cerebellar Purkinje cells in autism spectrum disorders.

Authors:  Anamaria Sudarov
Journal:  Cerebellum       Date:  2013-12       Impact factor: 3.847

10.  Cerebellar brain-derived neurotrophic factor, nerve growth factor, and neurotrophin-3 expression in male and female rats is differentially affected by hypergravity exposure during discrete developmental periods.

Authors:  Elizabeth M Sajdel-Sulkowska; Ming Xu; Noriyuki Koibuchi
Journal:  Cerebellum       Date:  2009-07-03       Impact factor: 3.847

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.